Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Cocaine Dependence
NCT00232336Phase 4Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Oct 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in cocaine dependence, sponsored by Seattle Institute for Biomedical and Clinical Research. Primary endpoints: Self-report of cocaine use at 6 weeks, Self-report of cocaine cravings at 6 weeks and 1 more. Started Oct 2003; status: completed.
02
Drugs
quetiapine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00232336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232336.